Health and Healthcare

Gilead Sciences : GILD

All Gilead Sciences Articles

732 Articles

Jon C. Ogg | Nov 21, 2013 at 7:25 AM EST

Solid Biotech Stocks With the Best Revenue Growth for 2014

ThinkstockAny time investors look for companies growing sales the most, one area that almost always stands out is the up…

Jon C. Ogg | Nov 19, 2013 at 11:50 AM EST

The $1 Trillion Drug Market Offers Great but Selective Growth in the Next Five Years

ThinkstockThe market for pharmaceuticals and biotech drugs just keeps growing. The so-called patent cliff may be affecting Big Pharma companies…

Lee Jackson | Nov 5, 2013 at 8:15 AM EST

UBS Adds Six Top Alpha Preference List Stocks to Buy for 2014

The Alpha Preference list of stocks to buy at UBS is comprised of companies that are the most preferred stocks…

Jon C. Ogg | Nov 2, 2013 at 7:15 AM EDT

Why Idenix Could Rise Even Higher, and Challenge Gilead and Vertex

ThinkstockIdenix Pharmaceuticals Inc. (NASDAQ: IDIX) was the biggest gainer of all listed stocks on Friday with a rally of 40%.…

Jon C. Ogg | Nov 1, 2013 at 8:25 AM EDT

Top Analyst Upgrades and Downgrades: Facebook, Netflix, PetSmart, Valero and More

Jon OggWe are nearing the end of earnings season, and stocks have challenged new all-time highs. Now investors are starting…

Trey Thoelcke | Oct 14, 2013 at 8:15 AM EDT

Jefferies Top Biotech Stocks to Buy

ThinkstockThe world of biotechnology investing is a constantly evolving and changing one. While disease for the most part does not…

Jon C. Ogg | Oct 8, 2013 at 2:47 PM EDT

Market Take: Biotech Suffers Under Government Shutdown Too!

ThinkstockThe field of pharmaceuticals is very well established and often is considered to be a very defensive sector. As such,…

Lee Jackson | Oct 3, 2013 at 11:50 AM EDT

Top Biotechs Set to Win in the War on Cancer

ThinkstockTuesday saw the wrap up of the 2013 European Society of Medical Oncology (ESMO) conference in Amsterdam, which featured key…

Lee Jackson | Sep 4, 2013 at 8:25 AM EDT

UBS Picks Large Cap Biotechnology Stocks to Outperform the Rest of 2013

ThinkstockEven though the equity strategy team at UBS has downgraded U.S. equities to Neutral from Outperform, they remain very positive…

Jon C. Ogg | Jul 31, 2013 at 8:35 AM EDT

UBS Updates and Adds Top Stocks to the Alpha Preference List

ThinkstockAlpha is one of those confusing terms that is used in the financial industry but rarely defined. It is basically…

Trey Thoelcke | Jul 3, 2013 at 8:10 AM EDT

Ten Top Large Cap Stocks to Buy With the Most Upside Potential

When we screen stocks at the Wall Street firms we cover, we always are anxious to provide our readers with…

Jon C. Ogg | Jun 13, 2013 at 8:15 AM EDT

Merrill Lynch Top Biotechnology Stocks to Buy for Big Gains

ThinkstockThe higher the market climbs, the harder it becomes for investors to find solid stock ideas to add or scale…

Jon C. Ogg | May 15, 2013 at 8:10 AM EDT

Deutsche Bank Firm on Biotech Stocks to Buy

ThinkstockBiotech has strongly outperformed the S&P 500 since January of 2011. The NASDAQ Biotechnology Index (NBI) is up 90%, and…

Paul Ausick | May 3, 2013 at 4:04 PM EDT

Closing Bell for Thursday on Wall Street: Markets Rise to New Highs on Jobs Report

U.S. equity markets opened higher this morning following upward revisions from the Bureau of Labor Statistics on non-farm payrolls in…

Paul Ausick | May 2, 2013 at 4:09 PM EDT

24/7 Wall St. Closing Bell — Thursday: Markets Open Higher, S&P Posts Another All-time High

U.S. equity markets opened higher this morning, buoyed by a smaller-than-expected total of new claims for unemployment benefits in the…

1 … 39 40 41 42 43 … 49

Gilead Sciences : GILD

All Gilead Sciences Articles

Solid Biotech Stocks With the Best Revenue Growth for 2014

The $1 Trillion Drug Market Offers Great but Selective Growth in the Next Five Years

UBS Adds Six Top Alpha Preference List Stocks to Buy for 2014

Why Idenix Could Rise Even Higher, and Challenge Gilead and Vertex

Top Analyst Upgrades and Downgrades: Facebook, Netflix, PetSmart, Valero and More

Jefferies Top Biotech Stocks to Buy

Market Take: Biotech Suffers Under Government Shutdown Too!

Top Biotechs Set to Win in the War on Cancer

UBS Picks Large Cap Biotechnology Stocks to Outperform the Rest of 2013

UBS Updates and Adds Top Stocks to the Alpha Preference List

Ten Top Large Cap Stocks to Buy With the Most Upside Potential

Merrill Lynch Top Biotechnology Stocks to Buy for Big Gains

Deutsche Bank Firm on Biotech Stocks to Buy

Closing Bell for Thursday on Wall Street: Markets Rise to New Highs on Jobs Report

24/7 Wall St. Closing Bell — Thursday: Markets Open Higher, S&P Posts Another All-time High

‘You’re Gonna Go Into Retirement Broke and Wait on Mom to Die’: Dave Ramsey’s Reality Check for a Caller Eyeing His Inheritance

“You Don’t Want to Pass the Burden of Investments Down to Your Daughter”: Suze Orman’s Advice to a 78-Year-Old With a Disabled Heir and $111K in Savings

EEM’s 0.69% Fee Quietly Costs You $690 a Year, but Your Cheaper Alternative Charges $90

'You're Gonna Go Into Retirement Broke and Wait on Mom to Die': Dave Ramsey's Reality Check for a Caller Eyeing His Inheritance

"You Don't Want to Pass the Burden of Investments Down to Your Daughter": Suze Orman's Advice to a 78-Year-Old With a Disabled Heir and $111K in Savings

‘You’re Gonna Go Into Retirement Broke and Wait on Mom to Die’: Dave Ramsey’s Reality Check for a Caller Eyeing His Inheritance

“You Don’t Want to Pass the Burden of Investments Down to Your Daughter”: Suze Orman’s Advice to a 78-Year-Old With a Disabled Heir and $111K in Savings

Gilead Sciences : GILD

All Gilead Sciences Articles

Solid Biotech Stocks With the Best Revenue Growth for 2014

The $1 Trillion Drug Market Offers Great but Selective Growth in the Next Five Years

UBS Adds Six Top Alpha Preference List Stocks to Buy for 2014

Why Idenix Could Rise Even Higher, and Challenge Gilead and Vertex

Top Analyst Upgrades and Downgrades: Facebook, Netflix, PetSmart, Valero and More

Jefferies Top Biotech Stocks to Buy

Market Take: Biotech Suffers Under Government Shutdown Too!

Top Biotechs Set to Win in the War on Cancer

UBS Picks Large Cap Biotechnology Stocks to Outperform the Rest of 2013

UBS Updates and Adds Top Stocks to the Alpha Preference List

Ten Top Large Cap Stocks to Buy With the Most Upside Potential

Merrill Lynch Top Biotechnology Stocks to Buy for Big Gains

Deutsche Bank Firm on Biotech Stocks to Buy

Closing Bell for Thursday on Wall Street: Markets Rise to New Highs on Jobs Report

24/7 Wall St. Closing Bell — Thursday: Markets Open Higher, S&P Posts Another All-time High

‘You’re Gonna Go Into Retirement Broke and Wait on Mom to Die’: Dave Ramsey’s Reality Check for a Caller Eyeing His Inheritance

“You Don’t Want to Pass the Burden of Investments Down to Your Daughter”: Suze Orman’s Advice to a 78-Year-Old With a Disabled Heir and $111K in Savings

EEM’s 0.69% Fee Quietly Costs You $690 a Year, but Your Cheaper Alternative Charges $90

Featured Reads

'You're Gonna Go Into Retirement Broke and Wait on Mom to Die': Dave Ramsey's Reality Check for a Caller Eyeing His Inheritance

"You Don't Want to Pass the Burden of Investments Down to Your Daughter": Suze Orman's Advice to a 78-Year-Old With a Disabled Heir and $111K in Savings